Mounjaro has been shown to produce an average 15.7% reduction in body weight, with almost a third of participants experiencing a reduction exceeding 20%
Darren McGuire, M.D., M.H.Sc., a Professor in UT Southwesterns Department of Internal Medicine and member of the Division of Cardiology, has played leadership roles in many of the trials over the last 15 years that have tested the cardiovascular safety of drugs used to treat type 2 diabetes
The slowing isnt failure
Based on receptor profile and emerging research trends: For appetite suppression alone GLP-1 agonists are effective For enhanced incretin signalling Tirzepatide expands the pathway For multi-pathway metabolic modulation Retatrutide currently appears the most comprehensive Secretagogues may support lean mass preservation
Semaglutide: The Single Agonist Think of GLP-1 as your bodys natural signal for Ive had enough to eat. After a meal, it helps communicate fullness to the brain, slows how quickly food leaves the stomach, and reduces the urge to keep eating
Presented for research literature review only Rea MS et al